0001601830-24-000098.txt : 20240703 0001601830-24-000098.hdr.sgml : 20240703 20240703163955 ACCESSION NUMBER: 0001601830-24-000098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dar Zavain CENTRAL INDEX KEY: 0001852075 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40323 FILM NUMBER: 241100633 MAIL ADDRESS: STREET 1: C/O LUX CAPITAL MANAGEMENT, LLC STREET 2: 1600 EL CAMINO REAL - SUITE 290 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001601830 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464099738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: (385) 269-0203 MAIL ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 FORMER COMPANY: FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20140305 4 1 wk-form4_1720039188.xml FORM 4 X0508 4 2024-07-01 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001852075 Dar Zavain C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 0 0 0 0 Class A Common Stock 2024-07-01 4 A 0 1843 0 A 103996 D The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. /s/ Jonathan Golightly, attorney-in-fact 2024-07-03